Strong Attack • Hubei Yichang On "Peptide" Health

In 2021, April 15-18, the "Fourth Bioactive Peptide Health Industry Forum-Product Innovation, Functional Research and Production Application Key Technology Seminar" and the Bioactive Peptide Health Industry Alliance Member Mobilization Meeting will be held in Yichang, Hubei . With the theme of "Bioactive Peptides—Life Commander, Source of Health", the conference will focus on the main topics of bioactive peptide product innovation, bioactive peptide function research and application, new bioactive peptide technology, new technology and new equipment, etc. 

In the context of the new crown epidemic, people have regarded health as more important than ever. Governments in various countries have paid more attention to the health industry than ever before, and are increasing investment and policy adjustments in this field. In recent years, China has vigorously adjusted its health policy and rebuilt its health concept. In the "14th Five-Year Plan" issued in October 2020, "life and health" has been listed as one of the eight major national science and technology projects. The National Development and Reform Commission and the Ministry of Industry and Information Technology jointly put forward the "Guiding Opinions on Promoting the Healthy Development of the Food Industry." Under this background, it undoubtedly brings more development opportunities and space to the health industry.

It is reported that this conference invited leaders of relevant national departments, well-known experts and scholars in the industry, and outstanding business representatives to further solve the key issues of technological innovation in the bioactive peptide industry, carry out technical cooperation, accelerate the transfer and transformation of scientific and technological achievements, and enhance the overall industry Competitiveness, providing talent support for the continuous innovation of the industry.

As a scientific and technological innovation enterprise in China's peptide industry and a comprehensive service provider for the global peptide industry, Taiaitai Group has attracted much attention in every industry event. Strongly attending with technology and quality products.

Taiaitai Group • Do not forget the original intention • Forge ahead

Established in 1997, Taiaitai Group is a group company integrating R&D, production, sales and service. It is a technologically innovative enterprise in China's peptide industry and a comprehensive service provider for the global peptide industry. For 24 years, Taiaitai has focused on the whole industry chain service of small molecule peptides, and the market covers multiple business sectors such as general health, special diet, cosmetics, and international trade. The group has always been adhering to the mission of "Let the common people drink peptides and have a good body", advocate the whole people to supplement peptides, and have always been committed to the development of the human health industry, with the mission of benefiting human health, creating a century-old health brand and helping healthy China!

Enterprise Honor:

Taiaitai focuses on scientific research and innovation in the small molecule peptide industry. It is the promoter of the global small molecule peptide industry and a comprehensive service provider for the entire industry chain of small molecule peptides. It has been widely praised at home and abroad.

Intellectual Property:

Taiaitai has mastered a number of core technology patents in the peptide industry: full-material chain extraction technology, single-material capture technology, own enzymatic hydrolysis technology, and mastered the core technology of herbal small molecule peptide extraction technology.

The group now has a number of national patents, more than 200 scientific research achievements, and more than 50 independent products. Provide global solutions for raw powder, OEM, brand agency, etc. It is a global high-level partner of Alibaba's peptide industry.

Scientific Research Strength:

Taiaitai has an international R & D team, most of them R & D personnel, have studied with Wu Qinglin for more than 8 years. Taiaitai has a 6000 square meter research and development building, and its scientific research investment continues to grow every year. At present, Taiaitai has developed more than 200 scientific and technological achievements and is the owner of a number of research and development patents in the peptide industry.

Production Ability:

The group has a modern production base of more than 400 acres, with an annual production capacity of more than 5,000 tons of small molecule peptide raw materials and products. In 2021, the new factory of Taiaitai Group signed a contract to settle in Shandong Heze Modern Pharmaceutical Port, which has taken another solid step in the development of the group.

In 2021, the 4th Bioactive Peptide Health Industry Forum will be launched from April 15 to 18, and it will be on the verge! Taiaitai Group hopes to work with the organizers of the conference and all those who are concerned about the development of the health industry to strengthen Theoretical research, implementation exploration, technological innovation, standard formulation, model guidance and policy and regulation research of the peptide health industry, actively promote the self-discipline of the active peptide industry and the coordinated development of the upstream and downstream of the industry chain, and create a bioactive peptide food, medicine and health industry. The main force contributes to the high-quality development of the big health industry.

If you love the big health industry, please consult the investment service hotline of Taiaitai Group for details:

Wang Chenghao 13716119111; Zhang Chengxin 18500153905; Fu Qiang: 13911681263